Buy G1 Therapeutics Stock | GTHX Stock Price & Latest News | Public
GTHX

G1 Therapeutics

$0.00 (0.00%)Today

    About GTHX

    G1 Therapeutics, Inc. engages in the development of small molecule therapeutics for the treatment of patients with cancer. Its products pipeline includes trilaciclib, rintodestrant, and lerociclib. The company was founded by Kwok-Kin Wong and Norman E. Sharpless on May ...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.29
    -0.59
    -0.88
    Q1 2020
    Q2 2020
    Q3 2020
    Q4 2020

    Expected EPS
    Q4 2020

    -$0.88

    Actual EPS
    Q4 2020

    Stats

    Market Cap$739,23M
    Volume35,38k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$31.38
    1 Year Low$8.80
    Open$19.43
    High$19.72
    Low$18.42

    Buy any stock with any amount of money.

    Download the App
    Download the app